Duration of chronic kidney disease reduces attention and executive function in pediatric patients

Susan R Mendley1, Matthew B Matheson2, Shlomo Shinnar3

  • 1University of Maryland School of Medicine, Baltimore, Maryland, USA.

Kidney International
|September 25, 2014
PubMed

Insights

Longer duration of childhood chronic kidney disease (CKD) is linked to poorer attention and inhibitory control. This finding emerged from a study of pediatric patients with mild-to-moderate CKD.

Area of Science:

  • Pediatric Nephrology
  • Neuropsychology
  • Child Health

Background:

  • Childhood chronic kidney disease (CKD) is associated with neurocognitive deficits.
  • Children with CKD often exhibit lower intelligence test scores compared to healthy siblings.

Purpose of the Study:

  • To investigate the association between CKD severity (eGFR, duration) and neurocognitive deficits in pediatric patients.
  • To identify specific cognitive functions affected by mild-to-moderate CKD in children.

Main Methods:

  • Assessed 340 pediatric patients (ages 6-21) with mild-to-moderate CKD using neurocognitive tests.
  • Utilized Conners' Continuous Performance Test-II (CPT-II), Delis-Kaplan Executive Function System Tower, and Digit Span Backward tasks.
  • Analyzed performance in relation to estimated glomerular filtration rate (eGFR) and CKD duration, controlling for covariates.

Main Results:

  • 35% of patients showed poor performance on at least one executive function test.
  • Longer CKD duration, not eGFR, was significantly associated with impaired attention regulation and inhibitory control (CPT-II Errors of Commission).

Conclusions:

  • In pediatric mild-to-moderate CKD, disease duration is a key factor impacting attention and inhibitory control.
  • Neurocognitive deficits, particularly in executive functions, are prevalent in children with CKD.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
673
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
676
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
350